www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

USEUROPEAFRICAASIA 中文雙語Fran?ais
China
Home / China / Health

Study: Doctors avoid best diabetes therapy

By Shan Juan | China Daily | Updated: 2017-04-18 07:26

Nearly 67 percent of people with diabetes in China have difficulty keeping their blood glucose within safe levels because of widespread "clinical inertia" - a reluctance to prescribe combination drug therapies that have proved effective in other countries - according to a new study.

Backed by pharmaceutical giant MSD, the study tracked more than 5,000 patients and 237 clinical research centers for almost a year. It is thought to be the largest study ever conducted in China on the treatment of Type 2 diabetes.

The findings were published in the first issue of Science China Life Sciences, an academic journal of the Chinese Academy of Sciences and the National Natural Science Foundation of China.

Research and clinical practice overseas has shown that a combination of the drugs metformin and sitagliptin is effective and safe. Other drugs may also be added for a triple effect.

But clinical inertia in China has undermined effective treatment, according to Wang Jianping, who led the study. Wang is director of diabetes care research at the Third Affiliated Hospital of Sun Yat-Sen University in Guangzhou, Guangdong province.

Many Chinese physicians do not prescribe combination therapies in a timely manner, which leads to patients having excessively high blood glucose levels over a long period, he said. Poor control over time can lead to health problems such as heart disease, as well as damage to the eyes, kidneys or nerves.

Doctors "are reluctant to prescribe combination therapies, largely due to a lack of clinical evidence and treatment consensus" in China, Wang said.

Mu Yiming, a senior diabetes specialist who was part of the study team, said the findings could help bridge the knowledge gap and help develop clinical evidence in China supporting combination drug treatments.

In addition, he said, "We're working closely to integrate the findings into the latest version of the national treatment guideline, which is due very soon".

Xing Xiaoyan, head of endocrinology at China-Japan Friendship Hospital, also stressed the importance of patient education. "It's hard to change behavior, and some patients tend to reject combination drug therapy, citing potential adverse reactions," Xing said.

She said the cost of drugs was a concern for many patients, but the government is helping.

"We've seen the government cover more diabetes treatments under public health insurance," she said.

According to the National Health and Family Planning Commission, China has about 113 million adults with Type 2 diabetes, roughly 25 percent of the global total.

Experts estimate that more than 493 million Chinese are prediabetic, which means their blood glucose levels are too high but not high enough for a diabetes diagnosis.

shanjuan@chinadaily.com.cn

Editor's picks
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 亚洲精品色一区二区三区 | 国产一区在线免费观看 | 欧美特黄一级片 | 亚洲欧美日韩国产专区一区 | 手机看片国产日韩 | 久久国产精品最新一区 | 成人做爰视频www | 日韩一区二区天海翼 | 理论片我不卡在线观看 | 日本加勒比视频在线观看 | 久久婷婷影院 | 日韩特级毛片 | 武松金莲肉体交战在线观看 | 台湾精品视频在线观看 | 国产伦一区二区三区四区久久 | 日本免费一级 | 加勒比毛片 | 日韩性大片免费 | 日韩在线第一区 | 欧美视频久久 | 99免费在线观看视频 | 国产成人精品女人不卡在线 | 精品视频在线观看一区二区三区 | 不卡精品国产_亚洲人成在线 | 欧美国产日韩一区二区三区 | 奇米888四色在线精品 | 亚洲一区精品在线 | 欧美大尺度免费一级特黄 | 久草视频手机在线观看 | 精品日韩二区三区精品视频 | 国产精品欧美亚洲韩国日本 | 久操精品在线 | 欧美男人操女人 | 亚洲成a人片在线观看 欧美 | 日本免费网站视频www区 | 性盈盈影院67194 | 中文字幕成人免费视频 | 精品国产杨幂在线观看福利 | 精品一区二区三区在线观看l | 久久免费精品 | 国产一级精品毛片 |